Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond
American Journal of Hematology · 2023
DOI: 10.1002/ajh.26912 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Hematology, 2023. Verfasst von Régis Peffault de Latour und 1 weiteren Autor:innen. Beteiligte Einrichtung: French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Assistance Publique - Hôpitaux de Paris, Saint-Louis Hospital, U…. Hauptthemen laut MEDLINE: Hematology, Hemoglobinuria, Paroxysmal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Assistance Publique - Hôpitaux de Paris, Saint-Louis Hospital, Université Paris Cité, Paris, France.
- AORN San Giuseppe Moscati, Avellino, Italy.
- Federico II University, Naples, Italy.
ORCID-Profile: Régis Peffault de Latour, Antonio M Risitano
Zitieren
APA
Peffault de Latour, R., & Risitano, A. M. (2023). Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond. American Journal of Hematology. https://doi.org/10.1002/ajh.26912
Vancouver
Peffault de Latour R, Risitano AM. Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond. American Journal of Hematology. 2023. doi:10.1002/ajh.26912
BibTeX
@article{PeffaultdeLatour2023,
author = {Peffault de Latour, Régis and Risitano, Antonio M},
title = {Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond},
journal = {American Journal of Hematology},
year = {2023},
doi = {10.1002/ajh.26912}
}
EUVIMED